Related references
Note: Only part of the references are listed.Impact of Post-Transplantation Hypomagnesemia on Long-Term Graft and Patient Survival after Transplantation
Ofer Isakov et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2022)
An overview of diagnosis and management of drug-induced hypomagnesemia
George Liamis et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2021)
Euglycemic Ketoacidosis as a Complication of SGLT2 Inhibitor Therapy
Biff F. Palmer et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)
Effect of Dapagliflozin and Magnesium Supplementation on Renal Magnesium Handling and Magnesium Homeostasis in Metabolic Syndrome
Hwee-Yeong Ng et al.
NUTRIENTS (2021)
Genetic and drug-induced hypomagnesemia: different cause, same mechanism
Willem Bosman et al.
PROCEEDINGS OF THE NUTRITION SOCIETY (2021)
Molecular Mechanisms of Renal Magnesium Reabsorption
David H. Ellison et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)
An 8-year Analysis of Magnesium Status in Elite International Track & Field Athletes
N. Pollock et al.
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2020)
SGLT2 Inhibitors for Treatment of Refractory Hypomagnesemia: A Case Report of 3 Patients
Evan C. Ray et al.
KIDNEY MEDICINE (2020)
Effects of sodium glucose cotransporter 2 inhibitors on mineral metabolism in type 2 diabetes mellitus
Joanna Sophia J. Vinke et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2019)
Low gut microbiota diversity and dietary magnesium intake are associated with the development of PPI-induced hypomagnesemia
Lisanne M. M. Gommers et al.
FASEB JOURNAL (2019)
Correction of hypomagnesemia by dapagliflozin in patients with type 2 diabetes: A post hoc analysis of 10 randomized, placebo-controlled trials
Robert D. Toto et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2019)
Proton pump inhibitors and hypomagnesemia A meta-analysis of observational studies
Thawin Srinutta et al.
MEDICINE (2019)
Increase in cetuximab-induced skin rash and hypomagnesemia in patients receiving concomitant treatment with proton pump inhibitors (PPIs): a possible drug interaction?
Mahmoud Abu-Amna et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2019)
Tubular flow activates magnesium transport in the distal convoluted tubule
Eric H. J. Verschuren et al.
FASEB JOURNAL (2019)
Electrolytes disturbances after kidney transplantation
Liesbeth De Waele et al.
ACTA CLINICA BELGICA (2019)
Subcutaneous Magnesium Sulfate to Correct High-Output Ileostomy-Induced Hypomagnesemia
Mark J. Makowsky et al.
CASE REPORTS IN GASTROENTEROLOGY (2019)
Prevalence and outcomes of proton pump inhibitor associated hypomagnesemia in chronic kidney disease
John Hughes et al.
PLOS ONE (2018)
The Role of Magnesium in Neurological Disorders
Anna E. Kirkland et al.
NUTRIENTS (2018)
TRPM6 is Essential for Magnesium Uptake and Epithelial Cell Function in the Colon
Francesca Luongo et al.
NUTRIENTS (2018)
Long-term renal follow-up of children treated with cisplatin, carboplatin, or ifosfamide: a pilot study
Kelly R. McMahon et al.
PEDIATRIC NEPHROLOGY (2018)
Thiazide but not loop diuretics is associated with hypomagnesaemia in the general population
Brenda C. T. Kieboom et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2018)
Canagliflozin triggers the FGF23/1,25-dihydroxyvitamin D/PTH axis in healthy volunteers in a randomized crossover study
Jenny E. Blau et al.
JCI INSIGHT (2018)
Magnesium attenuates cisplatin-induced nephrotoxicity by regulating the expression of renal transporters
Yoshitaka Saito et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
Electrolyte Disturbances in Patients with Chronic Alcohol-Use Disorder
Biff F. Palmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
A Trial of Itraconazole or Amphotericin B for HIV-Associated Talaromycosis
Thuy Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Systematic Review and Meta-Analysis of Patiromer and Sodium Zirconium Cyclosilicate: A New Armamentarium for the Treatment of Hyperkalemia
Calvin J. Meaney et al.
PHARMACOTHERAPY (2017)
Parathyroid hormone controls paracellular Ca2+ transport in the thick ascending limb by regulating the tight-junction protein Claudin14
Tadatoshi Sato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Serum Magnesium and Related Factors in Long-Term Renal Transplant Recipients: An Observational Study
N. Rodrigues et al.
TRANSPLANTATION PROCEEDINGS (2017)
Antibiotic-associated diarrhea
Frank R. Giannelli
JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS (2017)
Effects of Canagliflozin on Serum Magnesium in Patients With Type 2 Diabetes Mellitus: A Post Hoc Analysis of Randomized Controlled Trials
Richard E. Gilbert et al.
DIABETES THERAPY (2017)
Effects of Canagliflozin on Serum Magnesium in Patients With Type 2 Diabetes Mellitus: A Post Hoc Analysis of Randomized Controlled Trials
Richard E. Gilbert et al.
DIABETES THERAPY (2017)
Intestinal Absorption and Factors Influencing Bioavailability of Magnesium-An Update
Jan Philipp Schuchardt et al.
CURRENT NUTRITION & FOOD SCIENCE (2017)
Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management
Bryan Oronsky et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Short-term proton pump inhibitor treatment may cause hypomagnesaemia in critically ill patients -a pilot study
Lukasz J. Krzych et al.
ACTA BIOCHIMICA POLONICA (2017)
Diabetes and kidney disease: the role of sodium-glucose cotransporter-2 (SGLT-2) and SGLT-2 inhibitors in modifying disease outcomes
Christian W. Mende
CURRENT MEDICAL RESEARCH AND OPINION (2017)
Management of Epidermal Growth Factor Receptor Inhibitor-Induced Hypomagnesemia: A Systematic Review
Di (Maria) Jiang et al.
CLINICAL COLORECTAL CANCER (2016)
Low Prevalence of Hypomagnesemia in Long-term Recipients of Proton Pump Inhibitors in a Managed Care Cohort
Ala I. Sharara et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Elevated serum magnesium associated with SGLT2 inhibitor use in type 2 diabetes patients: a meta-analysis of randomised controlled trials
Huilin Tang et al.
DIABETOLOGIA (2016)
Is there a relationship between hypomagnesemia and proton-pump inhibitors in patients on chronic hemodialysis?
I. Mikolasevic et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2016)
Electrolyte disorders associated with the use of anticancer drugs
George Liamis et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
New-Onset Diabetes After Kidney Transplantation and Pretransplant Hypomagnesemia
Ayse Sinangil et al.
PROGRESS IN TRANSPLANTATION (2016)
Incidence and Risk Factors of Hypomagnesemia in Head and Neck Cancer Patients Treated with Cetuximab
Tomohiro Enokida et al.
FRONTIERS IN ONCOLOGY (2016)
Perspective: The Case for an Evidence-Based Reference Interval for Serum Magnesium: The Time Has Come
Rebecca B. Costello et al.
ADVANCES IN NUTRITION (2016)
MAGNESIUM IN MAN: IMPLICATIONS FOR HEALTH AND DISEASE
Jeroen H. F. de Baaij et al.
PHYSIOLOGICAL REVIEWS (2015)
Possible adverse effects of SGLT2 inhibitors on bone
Simeon I. Taylor et al.
LANCET DIABETES & ENDOCRINOLOGY (2015)
Electrolyte disorders assessment in solid tumor patients treated with anti-EGFR monoclonal antibodies: a pooled analysis of 25 randomized clinical trials
Qiaoli Wang et al.
TUMOR BIOLOGY (2015)
Magnesium and type 2 diabetes
Mario Barbagallo et al.
WORLD JOURNAL OF DIABETES (2015)
Downregulation of transient receptor potential M6 channels as a cause of hypermagnesiuric hypomagnesemia in obese type 2 diabetic rats
Kaori Takayanagi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2015)
An open-label single-arm, phase II trial of zalutumumab, a human monoclonal anti-EGFR antibody, in patients with platinum-refractory squamous cell carcinoma of the head and neck
Vassiliki Saloura et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
Effect of canagliflozin on serum electrolytes in patients with type 2 diabetes in relation to estimated glomerular filtration rate (eGFR)
Matthew R. Weir et al.
CURRENT MEDICAL RESEARCH AND OPINION (2014)
Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients
Ele Ferrannini et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Magnesium loss in cyclosporine-treated patients is related to renal epidermal growth factor downregulation
Kristien J. Ledeganck et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Magnesium excretion and hypomagnesemia in pediatric renal transplant recipients
Arife Uslu Gokceoglu et al.
RENAL FAILURE (2014)
Contemporary view of the clinical relevance of magnesium homeostasis
John Ayuk et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2014)
Hypomagnesemia: a clinical perspective
Phuong-Chi T. Pham et al.
INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE (2014)
Proton pump inhibitors and hypomagnesemia: a rare but serious complication
Mark A. Perazella
KIDNEY INTERNATIONAL (2013)
Cisplatin-induced injury of the renal distal convoluted tubule is associated with hypomagnesaemia in mice
Annelies A. van Angelen et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Systematic review: hypomagnesaemia induced by proton pump inhibition
M. W. Hess et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Claudin-14 regulates renal Ca++ transport in response to CaSR signalling via a novel microRNA pathway
Yongfeng Gong et al.
EMBO JOURNAL (2012)
Decrease in transient receptor potential melastatin 6 mRNA stability caused by rapamycin in renal tubular epithelial cells
Akira Ikari et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2011)
A Case Series of Proton Pump Inhibitor-Induced Hypomagnesemia
Ewout J. Hoorn et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
Hypomagnesemia and the Risk of New-Onset Diabetes after Liver Transplantation
Steven Van Laecke et al.
LIVER TRANSPLANTATION (2010)
Changes in Magnesium and Potassium Homeostasis after Conversion from a Calcineurin Inhibitor Regimen to an mTOR Inhibitor-Based Regimen
A. I. Sanchez-Fructuoso et al.
TRANSPLANTATION PROCEEDINGS (2010)
Magnesemia in Renal Transplant Recipients: Relation With Immunosuppression and Posttransplant Diabetes
J. M. Osorio et al.
TRANSPLANTATION PROCEEDINGS (2010)
Review: Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management
Alexander Stein et al.
Therapeutic Advances in Medical Oncology (2009)
Spurious hyperkalaemia due to EDTA contamination: common and not always easy to identify
Michael P. Comes et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2008)
Impaired basolateral sorting of pro-EGF causes isolated recessive renal hypomagnesemia
Wouter M. Tiel Groenestege et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Nephrotoxicity of cisplatin and carboplatin in sarcoma patients:: A report from the late effects surveillance system
W. Stoehr et al.
PEDIATRIC BLOOD & CANCER (2007)
Proton-pump inhibitors and hypomagnesemic hypoparathyroidism
Martin Epstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Dysregulation of renal sodium transporters in gentamicin-treated rats
M. C. Sassen et al.
KIDNEY INTERNATIONAL (2006)
Effects of immunosuppressive agents on magnesium metabolism early after allogeneic hematopoietic stem cell transplantation
Y Aisa et al.
TRANSPLANTATION (2005)
Cetuximab therapy and symptomatic hypomagnesemia
D Schrag et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Long-term effect of a plant-based diet on magnesium status during pregnancy
C Koebnick et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2005)
Drug-induced hypomagnesaemia - Scope and management
J Atsmon et al.
DRUG SAFETY (2005)
Kidney slices of human and rat to characterize cisplatin-induced injury on cellular pathways and morphology
AEM Vickers et al.
TOXICOLOGIC PATHOLOGY (2004)
Cisplatin-induced hypokalemic paralysis
M Mohammadianpanah et al.
CLINICAL THERAPEUTICS (2004)
Role of hypomagnesemia in chronic cyclosporine nephropathy
K Miura et al.
TRANSPLANTATION (2002)
Cyclosporine A neurotoxicity in a patient with idiopathic renal magnesium wasting
AK Al-Rasheed et al.
PEDIATRIC NEUROLOGY (2000)
Gentamicin effects on urinary electrolyte excretion in healthy subjects
C Elliott et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
Share Paper
